e-learning
resources
London 2016
Monday, 05.09.2016
Long-term outcomes of lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence, outcomes and risk factors for neoplasms in explanted lungs
Manel El Andaloussi (Bordeaux, France), Manel El Andaloussi, Xavier Demant, Elodie Blanchard, Julie Macey, Hadrien Roze, Matthieu Rigaud, Jacques Jougon, Hugues Begueret, Chantal Raherison, Manuel Tunon De Lara, Claire Dromer
Source:
International Congress 2016 – Long-term outcomes of lung transplantation
Session:
Long-term outcomes of lung transplantation
Session type:
Thematic Poster
Number:
2534
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Manel El Andaloussi (Bordeaux, France), Manel El Andaloussi, Xavier Demant, Elodie Blanchard, Julie Macey, Hadrien Roze, Matthieu Rigaud, Jacques Jougon, Hugues Begueret, Chantal Raherison, Manuel Tunon De Lara, Claire Dromer. Incidence, outcomes and risk factors for neoplasms in explanted lungs. Eur Respir J 2016; 48: Suppl. 60, 2534
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung cancer in patients with idiopathic pulmonary fibrosis:
Clinical characteristics and impact on survival
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Neoplasia in patients with ILD; shortened survival
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis?
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Pleuroparenchymal fibroelastosis (PPFE) – Resembling features in patients with malignancies
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Correlation between clinical and pathological factors in resected lung carcinoid tumours
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Clinical and therapeutic characteristics of patients died due to radiation-induced pneumonitis
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Long-term impact of developing a postoperative pulmonary complications after lung surgery
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
A case series of eight patients treated with alectinib including a case of interstitial lung disease
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016
Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Rare primary pulmonary tumors
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Source: International Congress 2014 – ILDs 3
Year: 2014
Pulmonary artery sarcoma. Complex problems with a rare tumor
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Malignant tumours in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Sclerosing hemangioma of the lung: Report of 4 cases
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept